e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 24, 2007
| |
|
|
| |
Biogen Idec Inc. |
|
| |
(Exact name of registrant as specified in its charter) |
|
| |
|
|
|
|
| Delaware
|
|
0-19311
|
|
33-0112644 |
| (State or other jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
| of incorporation) |
|
|
|
Identification No.) |
| |
|
|
|
|
| |
14 Cambridge Center, Cambridge, Massachusetts
|
|
02142 |
|
| |
(Address of principal executive offices) |
|
(Zip Code) |
|
Registrant’s
telephone number, including area code (617) 679-2000
| |
|
|
| |
Not Applicable |
|
| |
(Former name or former address, if changed since last report) |
|
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| |
|
|
| Item 2.02 |
|
Results of Operations and Financial Condition. |
On July 24, 2007, the registrant issued
a press release announcing its results of operations and financial condition for the three months
ended June 30, 2007. A copy of the press release is furnished as Exhibit 99.1 and is incorporated
herein by reference.
The press release
is being furnished pursuant to Item 2.02 of this Current Report on Form 8-K and shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange
Act”) or otherwise subject to the liabilities of that Section, nor shall such document be
deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange
Act.
| |
|
|
| Item 9.01 |
|
Financial Statements and Exhibits. |
| |
|
|
| |
99.1 |
Registrant’s press release dated July 24, 2007. |
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
| |
Biogen Idec Inc. |
| |
|
|
|
| |
|
|
|
| |
By: |
/s/ Robert A. Licht |
|
| |
|
|
|
| |
|
Robert A. Licht |
|
| |
|
Vice President and
Assistant Secretary |
|
Date: July 24, 2007
EXHIBIT INDEX
| |
|
|
Exhibit
Number |
|
Description |
| |
| 99.1 |
|
Registrant’s press release dated July 24, 2007.
|